New York State Common Retirement Fund
KRON

New York State Common Retirement Fund’s Kronos Bio KRON Stock Holding History

New York State Common Retirement Fund’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-366
Closed -$630 – 3327
2023
Q2 		$630 Sell
366
-27,700
-99% -$44K ﹤0.01% 3349
2023
Q1 		$41K Hold
28,066
– – ﹤0.01% 3029
2022
Q4 		$45.5K Hold
28,066
– – ﹤0.01% 3101
2022
Q3 		$94K Buy
28,066
+114
+0.4% +$515 ﹤0.01% 3035
2022
Q2 		$102K Sell
27,952
-89
-0.3% -$403 ﹤0.01% 3051
2022
Q1 		$203K Buy
28,041
+13
+0% +$111 ﹤0.01% 2813
2021
Q4 		$381K Sell
28,028
-65
-0.2% -$1.02K ﹤0.01% 2585
2021
Q3 		$589K Sell
28,093
-5,337
-16% -$115K ﹤0.01% 2369
2021
Q2 		$801K Buy
33,430
+20,230
+153% +$512K ﹤0.01% 2335
2021
Q1 		$386K Buy
13,200
+1,800
+16% +$52.7K ﹤0.01% 2558
2020
Q4 		$341K Buy
+11,400
New +$358K ﹤0.01% 2530

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund's KRON Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 366 shares — an estimated $630 sold.

New York State Common Retirement Fund first reported a position in KRON in Q4 2020 and held it in 11 quarters. The position peaked at $801K in Q2 2021. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 366 Kronos Bio shares in Q3 2023, an estimated $630.
  • New York State Common Retirement Fund first reported a position in Kronos Bio in Q4 2020 and held it in 11 quarters.
  • New York State Common Retirement Fund's Kronos Bio position peaked at $801K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.